See also this year's filing and all EDGAR filings for this company.
PDF Report 0000912183_2013_Cubist_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| info | NetIncome node detected by tax heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'} |
Graph
Absolute values for 0000912183, Cubist Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 1,157,050,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 266,960,000 |
| 2 | PropertyPlantAndEquipmentNet | 166,465,000 |
| 3 | remainder_Assets | 341,910,000 |
| 4 | LiabilitiesCurrent | 258,518,000 |
| 5 | LiabilitiesNoncurrent | 27,921,000 |
| 6 | remainder_Liabilities | 655,198,000 |
| 7 | CostOfGoodsAndServicesSold | 230,057,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 171,788,000 |
| 9 | ResearchAndDevelopmentExpense | 277,729,000 |
| 10 | remainder_Expenses | 55,200,000 |
| 11 | remainder_Revenues | 926,359,000 |
| 12 | remainder_NetIncome | -37,510,000 |
| 13 | remainder_ComprehensiveNetIncome | 126,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,932,385,000 |
| 1 | Liabilities | 941,637,000 |
| 2 | Expenses | 734,774,000 |
| 3 | Revenues | 926,359,000 |
| 4 | StockholdersEquity | 990,748,000 |
| 5 | NetIncome | 154,075,000 |
| 6 | ComprehensiveNetIncome | 154,138,000 |
| 7 | BaseVar | 2,286,395,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.61 |
| 9 | EconomicCapitalRatio | 2.76 |
Edgar->Model Mapping
Feature Distribution
Change over Time
